Medicare Enrolled
Dr. Bety Ciobanu, MD
Hematology & Oncology · Chicago, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ciobanu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ciobanu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ciobanu
Dr. Bety Ciobanu is a hematology & oncology specialist in Chicago, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ciobanu performed 77,068 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ciobanu received a total of $25,741 from 106 pharmaceutical and/or device companies across 861 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ciobanu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 15% volume in IL
$25,741 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗77,068
Medicare services
Top 15% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
42,545 | $2 | $20 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
15,300 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,300 | $18 | $67 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,000 | $0 | $6 |
| Iron infusion (Monoferric) | 1,800 | $16 | $71 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
980 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 650 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $99 | $231 |
| Anti-nausea injection (Aloxi/palonosetron) | 490 | $1 | $114 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
462 | $11 | $93 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
228 | $83 | $824 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
218 | $147 | $325 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
207 | $66 | $157 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
180 | $108 | $686 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $69 | $168 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
170 | $23 | $152 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
150 | $13 | $105 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
115 | $60 | $205 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
105 | $52 | $304 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
86 | $107 | $297 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
73 | $23 | $156 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
72 | $1 | $17 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
59 | $69 | $70 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
56 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
52 | $53 | $334 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
30 | $99 | $232 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
27 | $27 | $249 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $87 | $219 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $145 | $412 |
| New patient office visit, complex (60-74 min) | 13 | $171 | $432 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.9% high complexity
75.4% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,741
Total received (2018-2024)
Avg $3,677/year across 7 years
Top 18% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
106
Companies
861
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,137
2023
$8,239
2022
$3,092
2021
$1,857
2020
$980
2019
$1,897
2018
$1,540
Payments by company (2024)
TAIHO ONCOLOGY, INC.
$1,423
BeiGene USA, Inc.
$1,419
AstraZeneca Pharmaceuticals LP
$1,285
Novartis Pharmaceuticals Corporation
$465
PFIZER INC.
$349
Janssen Biotech, Inc.
$303
E.R. Squibb & Sons, L.L.C.
$213
Merck Sharp & Dohme LLC
$191
ABBVIE INC.
$190
JAZZ PHARMACEUTICALS INC.
$188
Daiichi Sankyo Inc.
$178
Eisai Inc.
$150
Pharmacosmos Therapeutics Inc.
$140
Astellas Pharma US Inc
$134
Regeneron Healthcare Solutions, Inc.
$120
Celgene Corporation
$83
Lilly USA, LLC
$78
SERVIER PHARMACEUTICALS LLC
$74
Dendreon Pharmaceuticals LLC
$67
Amneal Pharmaceuticals LLC
$67
Gilead Sciences, Inc.
$67
SpringWorks Therapeutics, Inc.
$63
GlaxoSmithKline, LLC.
$57
SOBI, INC
$57
Genentech USA, Inc.
$54
Menarini Silicon Biosystems, Inc.
$48
Incyte Corporation
$44
EMD Serono, Inc.
$43
Kyowa Kirin, Inc.
$42
GE HEALTHCARE
$34
Takeda Pharmaceuticals U.S.A., Inc.
$34
ARRAY BIOPHARMA INC
$32
Mirati Therapeutics, Inc.
$30
TerSera Therapeutics LLC
$30
Tempus AI, Inc
$30
Blueprint Medicines Corporation
$29
Deciphera Pharmaceuticals Inc.
$26
Agios Pharmaceuticals, Inc.
$26
Immunocore Limited
$24
Azurity Pharmaceuticals, Inc.
$23
Apellis Pharmaceuticals, Inc.
$23
Stemline Therapeutics Inc.
$21
Coherus Biosciences Inc.
$21
Rigel Pharmaceuticals, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Kite Pharma, Inc.
$19
GENZYME CORPORATION
$18
Fennec Pharmaceuticals, Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Genmab U.S., Inc.
$16
Biocon Biologics Inc
$16
Epizyme, Inc.
$15
Iovance Biotherapeutics, Inc.
$6
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,496
Janssen Biotech, Inc.
$2,132
Novartis Pharmaceuticals Corporation
$1,735
TAIHO ONCOLOGY, INC.
$1,464
SERVIER PHARMACEUTICALS LLC
$1,464
BeiGene USA, Inc.
$1,463
AVEO Pharmaceuticals, Inc.
$1,411
Amgen Inc.
$947
PFIZER INC.
$873
Genentech USA, Inc.
$734
E.R. Squibb & Sons, L.L.C.
$558
Merck Sharp & Dohme LLC
$512
JAZZ PHARMACEUTICALS INC.
$499
Incyte Corporation
$492
Astellas Pharma US Inc
$459
Lilly USA, LLC
$410
Merck Sharp & Dohme Corporation
$410
Gilead Sciences, Inc.
$377
Daiichi Sankyo Inc.
$371
Celgene Corporation
$350
GENZYME CORPORATION
$316
ABBVIE INC.
$305
Eisai Inc.
$296
TG THERAPEUTICS, INC.
$272
Bayer HealthCare Pharmaceuticals Inc.
$270
EMD Serono, Inc.
$261
AbbVie Inc.
$256
Pharmacyclics LLC, An AbbVie Company
$221
GlaxoSmithKline, LLC.
$219
Regeneron Healthcare Solutions, Inc.
$209
Seagen Inc.
$195
Takeda Pharmaceuticals U.S.A., Inc.
$185
Deciphera Pharmaceuticals Inc.
$157
Pharmacosmos Therapeutics Inc.
$156
Boston Scientific Corporation
$140
EISAI INC.
$127
Kite Pharma, Inc.
$123
G1 Therapeutics, Inc.
$118
Kyowa Kirin, Inc.
$111
Boehringer Ingelheim Pharmaceuticals, Inc.
$109
Janssen Pharmaceuticals, Inc
$99
Karyopharm Therapeutics Inc.
$98
PUMA BIOTECHNOLOGY, INC.
$90
Amneal Pharmaceuticals LLC
$85
PharmaEssentia USA Corporation
$79
SOBI, INC
$75
Epizyme, Inc.
$75
Mirati Therapeutics, Inc.
$74
Dendreon Pharmaceuticals LLC
$67
ADC Therapeutics America, Inc.
$66
TerSera Therapeutics LLC
$65
SpringWorks Therapeutics, Inc.
$63
TESARO, Inc.
$56
Blueprint Medicines Corporation
$55
Exelixis Inc.
$55
Puma Biotechnology, Inc.
$54
Coherus Biosciences Inc.
$51
Seattle Genetics, Inc.
$49
Menarini Silicon Biosystems, Inc.
$48
ARRAY BIOPHARMA INC
$48
Genentech, Inc.
$47
CTI BioPharma Corp.
$47
EUSA Pharma (US) LLC
$46
Genmab U.S., Inc.
$45
MorphoSys, US Inc.
$45
AMAG Pharmaceuticals, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$44
AbbVie, Inc.
$43
Agios Pharmaceuticals, Inc.
$43
Immunomedics, Inc.
$41
Epizyme, Inc.,
$38
GE HEALTHCARE
$34
Biocon Biologics Inc
$32
Tempus AI, Inc
$30
Adaptive Biotechnologies Corporation
$28
Helsinn Therapeutics (U.S.), Inc.
$27
NOVARTIS PHARMACEUTICALS CORPORATION
$26
Foundation Medicine, Inc.
$25
Mylan Institutional Inc.
$25
Immunocore Limited
$24
Pharmacyclics LLC, an AbbVie Company
$24
Organon LLC
$23
Azurity Pharmaceuticals, Inc.
$23
Apellis Pharmaceuticals, Inc.
$23
MACROGENICS, INC.
$22
Servier Pharmaceuticals LLC
$21
Stemline Therapeutics Inc.
$21
Alexion Pharmaceuticals, Inc.
$21
ImmunoGen, Inc.
$21
Rigel Pharmaceuticals, Inc.
$21
Verastem, Inc.
$20
Verity Pharmaceuticals Inc.
$19
Dova Pharmaceuticals
$18
TG Therapeutics, Inc.
$18
Medtronic USA, Inc.
$17
Fennec Pharmaceuticals, Inc.
$17
Advanced Accelerator Applications
$17
Jazz Pharmaceuticals Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Innate Pharma, Inc
$16
Ipsen Biopharmaceuticals, Inc
$16
Lexicon Pharmaceuticals, Inc.
$16
Sysmex Inostics Inc
$14
Fortovia Therapeutics, Inc.
$6
Iovance Biotherapeutics, Inc.
$6
Heron Therapeutics, Inc.
$3
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Amtagvi · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Columvi · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Fulphila · GILOTRIF · Halaven · Herceptin · Hulio · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · IRESSA · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LOQTORZI · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lumoxiti · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PREVYMIS · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SUTENT · SYNCHROMED · Soltamox · Somatuline Depot · SpyGlass · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TUKYSA · Tazverik · Tibsovo · Trelstar · Trodelvy · UKONIQ · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · Voranigo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
336
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
AMITA HEALTH RESURRECTION MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ciobanu is a mixed practice specialist, with above-average Medicare volume (top 15% in IL), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ciobanu experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Ciobanu performed 42,545 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ciobanu receive payments from pharmaceutical companies?
Yes. Dr. Ciobanu received a total of $25,741 from 106 companies across 861 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ciobanu's costs compare to other hematology & oncology specialists in Chicago?
Dr. Ciobanu's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ciobanu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Chicago
Browse hematology & oncology specialists in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology